Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320803755> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4320803755 abstract "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2), responsible for generating COVID-19, has spread worldwide and was declared a pandemic by the World Health Organization (WHO) on 11 March 2020, being responsible for various damages to public health, social life, and the economy of countries. Its high rates of infectivity and mortality have stimulated researchers and pharmaceutical companies to search for new therapies against this disease. The findings in recent years regarding the structure and biochemistry of SARS-CoV2 are remarkable. 3CLpro is a potential target as an anti-SARS agent as it plays a vital role in the viral life cycle. Another promising target is the transmembrane protease serine 2 (TMPRSS2). Recent studies point to TMPRSS2 as one of the main targets responsible for a viral entry related to the cleavage of the S protein. Similar to cathepsins, TMPRSS2 is also responsible for the cleavage of the spike protein SARS-CoV2, which binds to the ACE2 receptor. Also, TMPRSS2 is one of the targets that may represent new alternatives in treating SARS-CoV2. In addition, the multitarget approach has grown in recent years. The design and identification of drugs that act on multiple targets can be the next stage in drug discovery campaigns. Finally, here using a virtual screening protocol docking-based in a multitarget approach, the drugs Raloxifene, Saquinavir, AFP-168, and Valrubicin show a potential inhibition of 3CLpro and TMPRSS2 and can be evaluated in vitro assay to prove your potential" @default.
- W4320803755 created "2023-02-15" @default.
- W4320803755 creator A5045328085 @default.
- W4320803755 creator A5072460483 @default.
- W4320803755 creator A5077977026 @default.
- W4320803755 creator A5086341560 @default.
- W4320803755 date "2022-12-09" @default.
- W4320803755 modified "2023-10-14" @default.
- W4320803755 title "Virtual Screening Multitarget-Based Against 3CL<sup>pro</sup> and TMPRSS2 Reveals New Promising Drugs Against SARS-CoV-2." @default.
- W4320803755 doi "https://doi.org/10.3390/mol2net-08-13845" @default.
- W4320803755 hasPublicationYear "2022" @default.
- W4320803755 type Work @default.
- W4320803755 citedByCount "0" @default.
- W4320803755 crossrefType "proceedings-article" @default.
- W4320803755 hasAuthorship W4320803755A5045328085 @default.
- W4320803755 hasAuthorship W4320803755A5072460483 @default.
- W4320803755 hasAuthorship W4320803755A5077977026 @default.
- W4320803755 hasAuthorship W4320803755A5086341560 @default.
- W4320803755 hasBestOaLocation W43208037551 @default.
- W4320803755 hasConcept C103697762 @default.
- W4320803755 hasConcept C126322002 @default.
- W4320803755 hasConcept C159047783 @default.
- W4320803755 hasConcept C185592680 @default.
- W4320803755 hasConcept C2777648638 @default.
- W4320803755 hasConcept C2778042024 @default.
- W4320803755 hasConcept C2779134260 @default.
- W4320803755 hasConcept C3008058167 @default.
- W4320803755 hasConcept C524204448 @default.
- W4320803755 hasConcept C60644358 @default.
- W4320803755 hasConcept C70721500 @default.
- W4320803755 hasConcept C71924100 @default.
- W4320803755 hasConcept C74187038 @default.
- W4320803755 hasConcept C86803240 @default.
- W4320803755 hasConcept C98274493 @default.
- W4320803755 hasConceptScore W4320803755C103697762 @default.
- W4320803755 hasConceptScore W4320803755C126322002 @default.
- W4320803755 hasConceptScore W4320803755C159047783 @default.
- W4320803755 hasConceptScore W4320803755C185592680 @default.
- W4320803755 hasConceptScore W4320803755C2777648638 @default.
- W4320803755 hasConceptScore W4320803755C2778042024 @default.
- W4320803755 hasConceptScore W4320803755C2779134260 @default.
- W4320803755 hasConceptScore W4320803755C3008058167 @default.
- W4320803755 hasConceptScore W4320803755C524204448 @default.
- W4320803755 hasConceptScore W4320803755C60644358 @default.
- W4320803755 hasConceptScore W4320803755C70721500 @default.
- W4320803755 hasConceptScore W4320803755C71924100 @default.
- W4320803755 hasConceptScore W4320803755C74187038 @default.
- W4320803755 hasConceptScore W4320803755C86803240 @default.
- W4320803755 hasConceptScore W4320803755C98274493 @default.
- W4320803755 hasLocation W43208037551 @default.
- W4320803755 hasOpenAccess W4320803755 @default.
- W4320803755 hasPrimaryLocation W43208037551 @default.
- W4320803755 hasRelatedWork W120026478 @default.
- W4320803755 hasRelatedWork W1714666523 @default.
- W4320803755 hasRelatedWork W2050066772 @default.
- W4320803755 hasRelatedWork W2060171382 @default.
- W4320803755 hasRelatedWork W2071791280 @default.
- W4320803755 hasRelatedWork W2075802963 @default.
- W4320803755 hasRelatedWork W2092688629 @default.
- W4320803755 hasRelatedWork W2140899380 @default.
- W4320803755 hasRelatedWork W3208376648 @default.
- W4320803755 hasRelatedWork W4200127861 @default.
- W4320803755 isParatext "false" @default.
- W4320803755 isRetracted "false" @default.
- W4320803755 workType "article" @default.